Showing 1 - 20 results of 41 for search 'Robert L. Ferris', query time: 0.10s
Refine Results
-
1
-
2
Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands by Bratislav M. Janjic, Aditi Kulkarni, Aditi Kulkarni, Robert L. Ferris, Robert L. Ferris, Robert L. Ferris, Lazar Vujanovic, Lazar Vujanovic, Nikola L. Vujanovic, Nikola L. Vujanovic
Published 2022-03-01
Article -
3
-
4
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients by Zaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, Anet Valdés, Raghvendra M. Srivastava, Tatiana M. García-Bates, Esperanza Hechavarría, Zuyen González, Amnely González, Martha Lugiollo, Iván Cuevas, Carlos Frómeta, Braulio F. Mestre, Maria C. Barroso, Tania Crombet, Robert L. Ferris, Robert L. Ferris, Robert L. Ferris
Published 2017-06-01
Article -
5
Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer by Joel Thomas, Hong Wang, David A. Clump, David A. Clump, Robert L. Ferris, Robert L. Ferris, Umamaheswar Duvvuri, Umamaheswar Duvvuri, James Ohr, James Ohr, Dwight E. Heron, Dwight E. Heron, Dwight E. Heron
Published 2020-02-01
Article -
6
-
7
Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy by Dan P. Zandberg, Chang-Sook Hong, Andrew Swartz, Ronan Hsieh, Jennifer Anderson, Robert L. Ferris, Brenda Diergaarde, Theresa L. Whiteside
Published 2024-09-01
Article -
8
-
9
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT by Marie-Nicole Theodoraki, Saigopalakrishna Yerneni, William E. Gooding, James Ohr, David A. Clump, Julie E. Bauman, Robert L. Ferris, Theresa L. Whiteside
Published 2019-07-01
Article -
10
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions. by Erica C Nakajima, Charles Laymon, Matthew Oborski, Weizhou Hou, Lin Wang, Jennifer R Grandis, Robert L Ferris, James M Mountz, Bennett Van Houten
Published 2014-01-01
Article -
11
-
12
The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018 by Paolo A. Ascierto, Lisa H. Butterfield, Sandra Demaria, Robert L. Ferris, Gordon J. Freeman, Roger S. Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov
Published 2019-08-01
Article -
13
Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma by Guilherme Rabinowits, Michael R. Migden, Todd E. Schlesinger, Robert L. Ferris, Morganna Freeman, Valerie Guild, Shlomo Koyfman, Anna C. Pavlick, Neil Swanson, Gregory T. Wolf, Scott M. Dinehart
Published 2021-12-01
Article -
14
T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response by Benjamin A. Kansy, Gulidanna Shayan, Hyun-Bae Jie, Sandra P. Gibson, Yu L. Lei, Sven Brandau, Stephan Lang, Nicole C Schmitt, Fei Ding, Yan Lin, Robert L. Ferris
Published 2018-11-01
Article -
15
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule by Jerome Galon, Sandra Demaria, Lisa H. Butterfield, Robert L. Ferris, Howard L. Kaufman, Willem W. Overwijk, Francesco M. Marincola, Pamela S. Ohashi, Ira Mellman, Pierre G. Coulie, Samir N. Khleif, Suzanne L. Topalian
Published 2016-11-01
Article -
16
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy by Ranee Mehra, Ina Rhee, Naiyer Rizvi, Robert L Ferris, Hussein Tawbi, Matthew D Hellmann, Sarah B Goldberg, Ryan J Sullivan, Helen X Chen, Jong Chul Park, Foluso O Ademuyiwa, Z Alexander Cao
Published 2023-03-01
Article -
17
APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma by Daniel L. Faden, Krystle A. Lang Kuhs, Maoxuan Lin, Adam Langenbucher, Maisa Pinheiro, Meredith Yeager, Michael Cullen, Joseph F. Boland, Mia Steinberg, Sara Bass, James S. Lewis, Michael S. Lawrence, Robert L. Ferris, Lisa Mirabello
Published 2021-08-01
Article -
18
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire by Ahmad Tarhini, Yan Lin, Huang Lin, Zahra Rahman, Priyanka Vallabhaneni, Prateek Mendiratta, James F. Pingpank, Matthew P. Holtzman, Erik C. Yusko, Julie A. Rytlewski, Uma N. M. Rao, Robert L. Ferris, John M. Kirkwood
Published 2018-10-01
Article -
19
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors by Cindy A. Sander, Elizabeth A. Rush, Jian Shi, Lidia M. R. B. Arantes, Raymond J. Tesi, Mark A. Ross, Michael J. Calderon, Simon C. Watkins, John M. Kirkwood, Robert L. Ferris, Lisa H. Butterfield, Lazar Vujanovic
Published 2022-07-01
Article -
20
Differential impact of TIM-3 ligands on NK cell function by Xin Zhang, Lazar Vujanovic, Riyue Bao, Robert L Ferris, Tullia C Bruno, Aditi Kulkarni, Hridesh Banerjee, Housaiyin Li, Juncheng Wang, Lawrence P Kane, Pragati Upadhyay, Jennifer L Anderson, Onyedikachi Victor Onyekachi, Lidia M R B Arantes
Published 2025-01-01
Article